Related Experiment Video
Updated: Aug 16, 2025

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Outcomes of early versus delayed trabeculotomy for primary congenital glaucoma
Sebastião Cronemberger1, Artur W Veloso1, Pedro Lins1
1Department of Ophthalmology and Otorhinolaryngology of the Federal University of Minas Gerais, Belo Horizonte, Brazil.
Insights
Early trabeculotomy (TROC) in primary congenital glaucoma (PCG) patients significantly reduces intraocular pressure (IOP) and abnormal axial length (AL) compared to delayed TROC.
Area of Science:
- Ophthalmology
- Pediatric Ophthalmology
- Glaucoma Research
Background:
- Primary congenital glaucoma (PCG) is characterized by elevated intraocular pressure (IOP), leading to abnormal eye growth.
- Ab externo trabeculotomy (TROC) is a surgical procedure to manage PCG.
- The timing of TROC may influence treatment outcomes in children with PCG.
Purpose of the Study:
- To compare the efficacy of early versus delayed ab externo trabeculotomy (TROC) in managing primary congenital glaucoma (PCG).
- To assess the impact of TROC timing on intraocular pressure (IOP) and ocular growth parameters.
Main Methods:
- Retrospective comparison of children with PCG undergoing TROC at ≤6 months (early) versus >6 months (delayed).
- Collected data on intraocular pressure (IOP), horizontal corneal diameter (HCD), central corneal thickness (CCT), and axial length (AL).
- Follow-up assessments at 1, 3, 6, and 12 months post-surgery; AL compared to healthy controls.
Main Results:
- Early TROC (n=33 eyes) showed a significantly lower incidence of abnormal axial length (AL) at 12 months (41.9%) compared to delayed TROC (n=37 eyes) (88.6%).
- The mean IOP at 12 months post-surgery was lower in the early TROC group than in the delayed TROC group.
- Each 1-mmHg increase in preoperative IOP correlated with a 0.25-mmHg increase in IOP at 12 months.
Conclusions:
- Early TROC (≤6 months) is associated with better IOP control and a substantially reduced incidence of abnormal axial length (AL) in PCG patients.
- Timely surgical intervention in PCG is crucial for mitigating long-term ocular abnormalities.
- The findings support earlier surgical management for primary congenital glaucoma.
Purpose:
In patients with primary congenital glaucoma (PCG), elevated intraocular pressure (IOP) causes abnormal eye growth. This study compared the outcomes of children with PCG who underwent ab externo trabeculotomy (TROC) at age ≤ 6 months (early TROC) and of those who underwent TROC at age > 6 months (delayed TROC).
Methods:
Intraocular pressure, horizontal corneal diameter (HCD), central corneal thickness (CCT) and axial length (AL) were compared before TROC and at 1-, 3-, 6- and 12-month follow-up visits between the groups of children who underwent TROC until or after 6 months of age. The ALs of these groups were also compared with the ALs of healthy age-matched eyes examined under the same conditions.
Results:
Trabeculotomy was performed in 43 children: 18 (33 eyes) aged 6 months (group 1) and 25 (37 eyes) aged >6 months (group 2); the mean ages were 86.56 ± 53.64 and 504.48 ± 448.14 days, respectively. The mean pre- and 12-month postoperative IOP values were 15.97 ± 4.78/16.62 ± 4.85 and 9.77 ± 2.88/10.93 ± 4.83 mmHg, respectively. Delayed TROC was associated with abnormal AL in 31 (88.6%) out of 37 eyes, while after early TROC, only 13 (41.9%) out of 33 eyes had abnormal AL (chi-square, 8.00; p = 0.03). In multivariable analysis, each 1-mmHg increase in preoperative IOP was associated with a 0.25-mmHg increase at 12 months (p = 0.04). On average, the mean IOP of the delayed TROC group was higher than that of the early TROC group by 3.72 mmHg at postoperative month 12 (95% CI = 0.44-6.99; p = 0.02).
Conclusion:
Compared with delayed TROC, early TROC is associated with reduced IOP and substantially reduced incidence of abnormal AL at postoperative month 12.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview

